| 1 | Leon | Aarons | University of Manchester | U.K. |
| 2 | Anne-Valérie | Angerard | F. Hoffmann-La Roche | Switzerland |
| 3 | Silke | Appel-Dingemanse | Novartis Pharma | Switzerland |
| 4 | Daren | Austin | GlaxoSmithKline | UK |
| 5 | William | Bachman | GloboMax LLC | USA |
| 6 | Ludger | Banken | Hoffman-La Roche | Switzerland |
| 7 | Misba | Beerahee | GlaxoSmithKline | UK |
| 8 | Marcus | Bjornsson | AstraZeneca | Sweden |
| 9 | Graham | Blakey | AstraZeneca | UK |
| 10 | Sonja | Boettcher | MERCK KGaA | Germany |
| 11 | Michael | Borenstein | Biostat | USA |
| 12 | François | Bouzom | TECHNOLOGIE SERVIER | FRANCE |
| 13 | Margaret | Britto | Quintiles, Inc. | France |
| 14 | Rene | Bruno | Genentech, Inc. | USA |
| 15 | Thierry | Buclin | University Hospital | Switzerland |
| 16 | Sophie | Callies | University of Manchester | England |
| 17 | Vicente G. | Casabo | Universidad de Valencia | Spain |
| 18 | Bruce | Charles | University of Queensland | Australia |
| 19 | Chao | Chen | GlaxoSmithKline R & D | UK |
| 20 | Xuejun | Chen | Otsuka Maryland Research Institute | USA |
| 21 | Doug | Clarkson | Insightful | UK |
| 22 | Valerie | Cosson | EMF Consulting | France |
| 23 | Eugène | Cox | Pharsight Corporation | The Netherlands |
| 24 | Chantal | Csajka | University Hospital | Switzerland |
| 25 | Marie | Cullberg | AstraZeneca R&D | Sweden |
| 26 | Dinesh | De Alwis | ELI LILLY & COMPANY | UK |
| 27 | Annabelle | Diot | INSERM U436 | France |
| 28 | Oscar | Della Pasqua | GlaxoSmithKline | UK |
| 29 | Catherine | Dubruc | Sanofi-Synthelabo Research -CMPK Building 7 - | FRANCE |
| 30 | Vincent | Duval | Div. of Pharmacokinetics, Faculty of Pharmacy | Sweden |
| 31 | Andreas | Dr. Ehret | Boehringer Ingelheim Pharma KG | Germany |
| 32 | Stuart | Ellis | AstraZeneca | UK |
| 33 | Evelyn | Ellis-Grosse | Wyeth-Ayerst Research | USA |
| 34 | Lars | Erichsen | Novo Nordisk | Denmark |
| 35 | Farkad | Ezzet | Schering-Plough | USA |
| 36 | Christine | Falcoz | GlaxoSmithKline | Italy |
| 37 | Karin | Fattinger | Div. of Clinical Pharmacology/Toxicology | Switzerland |
| 38 | Jean-Baptiste | Fau | Sanofi-Synthelabo Research | France |
| 39 | Bärbel | Fotteler | F. Hoffmann - La Roche | Switzerland |
| 40 | Nicolas | Frey | I.R.I.S | FRANCE |
| 41 | Lena | Friberg | Div. of Pharmacokinetics and Drug Therapy, Uppsala University | Sweden |
| 42 | Eliane | Fuseau | EMF Consulting | France |
| 43 | Anne | Gardin | F Hoffmann-La Roche Ltd | Switzerland |
| 44 | Pascal | Girard | Pharsight | France |
| 45 | Mylene | Giraudon | NOVARTIS | SWITZERLAND |
| 46 | Sophie | Gisbert | EMF Consulting | France |
| 47 | Sophie | Glatt | EMF Consulting | France |
| 48 | Joga | Gobburu | FDA | USA |
| 49 | Timothy | Goggin | F. Hoffmann La-Roche | Switzerland |
| 50 | Roberto | Gomeni | GlaxoSmithKline | Italy |
| 51 | Gordon | Graham | University of Manchester | United Kingdom |
| 52 | Susan | Grange | Hoffmann-La Roche | Switzerland |
| 53 | Nina | Griese | Universitäts-Kinderklinik, Pädiatrische Hämatologie/ Onkologie | Germany |
| 54 | Bengt | Hamrén | AstraZeneca R&D Mölndal | Sweden |
| 55 | Lutz | Harnisch | Aventis | Germany |
| 56 | Vibeke | Hatorp | DTC | Denmark |
| 57 | Georg | Hempel | Universitätskliniken Münster, Kinderklinik, | Germany |
| 58 | Tracy | Higgins | Covance CRU | UK |
| 59 | Nils Ove | Hoem | Laboratory of Applied Pharmacokinetics, Keck School of Medicine, University of Southern California | USA |
| 60 | Nick | Holford | University of Auckland | New Zealand |
| 61 | Quyen | Ho-Nguyen | Serono International S.A. | Switzerland |
| 62 | Ziad | Hussein | Medeval Ltd | United Kingdom |
| 63 | Anna | Huusom | H. Lundbeck A/S | Denmark |
| 64 | Steen | Ingwersen | Novo Nordisk | Denmark |
| 65 | Peter | Jakobs | Schering AG | Germany |
| 66 | Judith | Jacobsen | Novo Nordisk | Denmark |
| 67 | Philippe | Jacqmin | Pharsight | Belgium |
| 68 | Roger | Jelliffe | USC School of Medicine | USA |
| 69 | Roeline | Jochemsen | I.R.I.S | FRANCE |
| 70 | Joost | DeJongh | LAP&P consultants | The Netherlands |
| 71 | Siv | Jönsson | Uppsala University | Sweden |
| 72 | Fredrik | Jonsson | National Institute for Working Life | Sweden |
| 73 | Niclas | Jonsson | Department of Pharmaceutical Bioscienses, Uppsala University | Sweden |
| 74 | Paul | Jordan | F.Hoffmann-La Roche AG | Switzerland |
| 75 | Yamamoto | Junichi | Novartis Pharma K.K. | Japan |
| 76 | Matts | Kågedal | AstraZeneca | Sweden |
| 77 | Marieke | De Kam | CHDR | Netherlands |
| 78 | Mats | Karlsson | Uppsala University | Sweden |
| 79 | Thomas | Kerbusch | Uppsala University | Sweden |
| 80 | Mary | Kennedy | Pharsight Corporation | UK |
| 81 | Hui | Kimko | Ctr for Drug Development Science | USA |
| 82 | Heidemarie | Kletzl | HOFFMANN LA ROCHE | SWITZERLAND |
| 83 | Charlotte | Kloft | Freie Universitaet Berlin | Germany |
| 84 | Ernst-Ulrich | Koelle | Novartis Pharma AG | Switzerland |
| 85 | Kazimierz H. | Kozlowski | Laboratory of Clinical Pharmacology, The Children's Memorial Health Institute | Poland |
| 86 | Andreas | Krause | Novartis Pharma | Switzerland |
| 87 | Christian | Laveille | SERVIER | France |
| 88 | Silvy | Laporte | Thrombosis Research Grooup, Clinical Pharmacology Unit | France |
| 89 | Bart | Laurijssens | GSK | UK |
| 90 | Robert | Leary | San Diego Supercomputer Center | USA |
| 91 | Laurence | Levasseur | Quintiles, Inc. | USA |
| 92 | Karl_Heinz | Liesenfeld | Boehringer Ingelheim Pharma KG | Germany |
| 93 | Lars | Lindbom | Uppsala University, Div of Pharmacokinetics and Drug Therapy, Dept of Pharmaceutical Biosciences | Sweden |
| 94 | Mª Carmen | Llopis Garcia | Hospital Universitario DR. PESET | Spain |
| 95 | Peter | Lloyd | Novartis | UK |
| 96 | Joern | Loetsch | Univ. of Frankfurt | Germany |
| 97 | Mick | Looby | Novartis | Switzerland |
| 98 | Philip | Lowe | Novartis | Switzerland |
| 99 | Eric | Luedin | Roche | Switzerland |
| 100 | Dave | Lunn | Imperial College School of Medicine | UK |
| 101 | Alex | MacDonald | Novartis Pharma AG | Switzerland |
| 102 | Ana | Martín Suárez | University of Salamanca | Spain |
| 103 | Ron | Mathôt | Netherlands Cancer Institute | Netherlands |
| 104 | Peter | McCormack | AstraZeneca | UK |
| 105 | Günther | Mehring | Novartis | Switzerland |
| 106 | Guy | Meno-Tetang | Novartis | Switzerland |
| 107 | Cédric | Mercier | Centre Léon-Bérard | France |
| 108 | Pierre | Maitre | - | Switzerland |
| 109 | Alan | Maloney | Pharsight | England |
| 110 | Véronique | Marcadé | Serono International | Switzerland |
| 111 | Scott | Marshall | Pfizer Global Research & Development | UK |
| 112 | DELPHINE | MARTIN | SERVIER RESEARCH AND DEVELOPMENT | UK |
| 113 | Ingolf | Meineke | Dept. Clinical Pharmacology, Göttingen | Germany |
| 114 | France | Mentre | dpt biostatictics - Hop Bichat | France |
| 115 | Yann | Merlé | INSERM U436 | France |
| 116 | Raymond | Miller | Pfizer, Inc. | U.S.A. |
| 117 | Peter | Milligan | Pfizer Global Research & Development | UK |
| 118 | Patrick | Mismetti | Clinical Pharmacology Unit | France |
| 119 | Diane | Mould | Georgetown University CDDS | USA |
| 120 | Alain | Munafo | Serono | Switzerland |
| 121 | In-Sun | Nam | University of Manchester | U.K. |
| 122 | Ivan | Nestorov | CAPKR - Manchester University | United Kingdom |
| 123 | Laurent | Nguyen | Institut de Recherche Pierre Fabre | France |
| 124 | Per | Olsson | Pharsight corp | UK |
| 125 | Emmanuelle | Ott | EMF Consulting | France |
| 126 | Roberto | Passera | torino university | italy |
| 127 | Bela | Patel | GlaxoSmithKline | USA |
| 128 | Christian | Pobel | CH SAINTES | FRANCE |
| 129 | Paulo | Paixão | UFNEB | Portugal |
| 130 | Anne | Pannier | Roche | France |
| 131 | Poul Chr. | Pedersen | Novo Nordisk A/S | Denmark |
| 132 | Juan José | Perez-ruixo | Hospital Universitario Dr. Peset | Spain |
| 133 | Olivier | Petricoul | EMF Consulting | France |
| 134 | Goonaseelan (Colin) | Pillai | F Hoffmann La-Roche | Switzerland |
| 135 | Vladimir | Piotrovskij | Janssen Research Foundation | Belgium |
| 136 | Maria | Pitsiu | Medeval Ltd | UK |
| 137 | Bart | Ploeger | LAP&P consultants | The Netherlands |
| 138 | Agnés | Portron | Equipe Médicament et barriére hématoencéphalique. Faculté de Pharmacie de Poitiers | France |
| 139 | Richard | Pugh | Insightful | UK |
| 140 | Amy | Racine | Novartis Pharma Inc | Switzerland |
| 141 | Stefanie | Reif | Freie Universitaet Berlin | Germany |
| 142 | Sylvie | Retout | INSERM U436 | FRANCE |
| 143 | Jakob | Ribbing | Uppsala University | Sweden |
| 144 | Myriam | Riek | F. Hoffmann - La Roche | Switzerland |
| 145 | Ferdie | Rombout | Bayer AG | Germany |
| 146 | Kieran | Rooney | Pharsight | UK |
| 147 | Maria | Rosario | Pfizer Ltd | UK |
| 148 | Amin | Rostami-H. | University of Sheffield | UK |
| 149 | Diether | Rueppel | Aventis Pharma | Germany |
| 150 | Ryosei | Kawai | Novartis Pharma K.K. | Japan |
| 151 | Marie | Sandström | Uppsala University | Sweden |
| 152 | Joseph | Schafer | Penn. state Univ | USA |
| 153 | Jakob | Schenker | Pharma Novartis AG | Switzerland |
| 154 | Brunhild | Schiltmeyer | University of Muenster, Pediatric Hematology and Oncology | Germany |
| 155 | Mari | Shiomi | Nippon Roche K.K. | Japan |
| 156 | Heinz | Schmidli | Novartis Pharma AG | Switzerland |
| 157 | Rik | Schoemaker | CHDR | Netherlands |
| 158 | Anita | Sharma | Insightful | UK |
| 159 | Lewis | Sheiner | UCSF | USA |
| 160 | Jagdev | Sidhu | GlaxoSmithKline | UK |
| 161 | Nicolas | Simon | Medical School of Marseille | France |
| 162 | Julie | Simpson | Department of General Practice and Primary Care | United Kingdom |
| 163 | Michael K. | Smith | Pfizer Global Research & Development | UK |
| 164 | Eric | Snoeck | Pharsight | UK |
| 165 | Miguel | Soares | Universidade de Lisboa - UDI | Portugal |
| 166 | Birgitte | Soegaard | H. Lundbeck A/S | Denmark |
| 167 | Alexander | Staab | - | UK |
| 168 | Jean-Louis | Steimer | F. Hoffmann-La Roche | Switzerland |
| 169 | Kerstin | Strandgården | AstraZeneca R&D Lund | Sweden |
| 170 | Ulrika | Svensson | Uppsala University | Sweden |
| 171 | Takeshi | Tajima | Novartis Pharma K.K. | Japan |
| 172 | Hideji | Tanaka | Kirin Brewery | JAPAN |
| 173 | Michel | Tod | Avicenne Hospital | FRANCE |
| 174 | Brigitte | Tranchand | Centre Léon-Bérard | France |
| 175 | Marc | Trellu | Sanofi-Synthélabo Research - CMPK Building 7 - | FRANCE |
| 176 | Iñaki | Troconiz | UNIVERSITY OF NAVARRA | SPAIN |
| 177 | Alison | Thomson | University of Glasgow | Scotland |
| 178 | Christiane | Tillmann | Eli Lilly and Company Ltd. | United Kingdom |
| 179 | Thomas Klitgaard | Tygesen | Novo Nordisk A/S | Denmark |
| 180 | Valéria | Molnár | AstraZeneca | England |
| 181 | Christine | Veyrat-Follet | AVENTIS PHARMA SA | FRANCE |
| 182 | Paolo | Vicini | University of Washington | United States |
| 183 | Peter | Vis | Pharsight | United Kingdom |
| 184 | Nicole | Vivier | Aventis Pharma SA | France |
| 185 | Janet | Wade | Pharsight | Sweden |
| 186 | Ulrika | Wählby | Div Pharmacokinetics and Drug Therapy, Uppsala University | Sweden |
| 187 | Gudrun | Wallenstein | Boehringer Ingelheim KG | Germany |
| 188 | Estelle | Watson | manchester university | England |
| 189 | Phil | Watson | Pharsight Corporation | England |
| 190 | Cornelia | Dr. Weber | Hoffmann-La Roche, Basel | Switzerland |
| 191 | Willi | Weber | Aventis | Germany |
| 192 | Horst A. | Welker | F,-Hoffmann-LaRoche Ltd. | Switzerland |
| 193 | Stefan | Wilde | Institut für Pharmakologie, Klinische Pharmakologie | Germany |
| 194 | Kristian | Windfeld | Novo Nordisk A/S | Denmark |
| 195 | Baerbel | Wittke | F.Hoffmann-La Roche Ltd | Switzerland |
| 196 | James G | Wright | Eli Lilly | UK |
| 197 | Guang | Wu | Novartis Pharma AG | Switzerland |
| 198 | Rujia | Xie | Uppsala University | Sweden |
| 199 | Per-Henrik | Zingmark | AstraZeneca R&D | Sweden |
| 200 | Klaas | Zuideveld | - | The Netherlands |